Regulation of innate and adaptive immunity using herbal medicine: benefits for the COVID-19 vaccination

Abstract

Vaccination is a major achievement that has become an effective prevention strategy against infectious diseases and active control of emerging pathogens worldwide. In response to the coronavirus disease 2019 (COVID-19) pandemic, several diverse vaccines against severe acute respiratory syndrome coronavirus 2 have been developed and deployed for use in a large number of individuals, and have been reported to protect against symptomatic COVID-19 cases and deaths. However, the application of vaccines has a series of limitations, including protective failure for variants of concern, unavailability of individuals due to immune deficiency, and the disappearance of immune protection for increasing infections in vaccinated individuals. These aspects raise the question of how to modulate the immune system that contributes to the COVID-19 vaccine protective effects. Herbal medicines are widely used for their immune regulatory abilities in clinics. More attractively, herbal medicines have been well accepted for their positive role in the COVID-19 prevention and suppression through regulation of the immune system. This review presents a brief overview of the strategy of COVID-19 vaccination and the response of the immune system to vaccines, the regulatory effects and mechanisms of herbal medicine in immune-related macrophages, natural killer cells, dendritic cells, and lymphocytes T and B cells, and how they help vaccines work. Later in the article, the potential role and application of herbal medicines in the most recent COVID-19 vaccination are discussed. This article provides new insights into herbal medicines as promising alternative supplements that may benefit from COVID-19 vaccination.

Keywords

COVID-19 / Herbal medicines / Immunity / Dendritic cells / Macrophage / Vaccine protection

References

[[1]] Canouï E, Launay O.History and principles of vaccination. Rev Mal Respir. 2019;36(1):74-81.

[[2]] Lopez Bernal J, Andrews N, Gower C, et al.Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on COVID-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088.

[[3]] Kestenbaum LA, Feemster KA.Identifying and addressing vaccine hesitancy. Pediatr Ann. 2015;44(4):e71-e75.

[[4]] Sobh A, Bonilla FA.Vaccination in primary immunodeficiency disorders. [J] Allergy Clin Immunol Pract. 2016;4(6):1066-1075.

[[5]] Squire JD, Joshi AY.Safety of COVID-19 vaccination in immune-deficient patients receiving supplemental immunoglobulin therapies. [J] Clin Immunol. 2021;41(7):1527-1530.

[[6]] Matta S, Rajpal S, Chopra KK, et al.Covid-19 vaccines and new mutant strains impacting the pandemic. Indian [J] Tuberc. 2021;68(2):171-173.

[[7]] Lopez E, Bosch-Camós L, Ramirez-Medina E, et al.Deletion mutants of the attenuated recombinant ASF virus, BA71ΔCD2, show decreased vaccine efficacy. Viruses. 2021;13(9):1678.

[[8]] Zhang Z, Mateus J, Coelho CH, et al.Humoral and cellular immune memory to four COVID-19 vaccines. bioRxiv. 2022;185(14):2434-2451.

[[9]] Palgen JL, Feraoun Y, Dzangué-Tchoupou G, et al.Optimize prime/boost vaccine strategies: trained immunity as a new player in the game. Front Immunol. 2021;12:612747.

[[10]] Cyranoski D.Why Chinese medicine is heading for clinics around the world. Nature. 2018;561(7724):448-450.

[[11]] Li L, Wu Y, Wang J, et al.Potential treatment of COVID-19 with traditional Chinese medicine: What herbs can help win the battle with SARS-CoV-2? Engineering. 2021.

[[12]] Zheng Z, Diaz-Arévalo D, Guan H, et al.Noninvasive vaccination against infectious diseases. Hum Vaccin Immunother. 2018;14(7):1717-1733.

[[13]] Buchy P, Ascioglu S, Buisson Y, et al.Impact of vaccines on antimicrobial resistance. Int [J] Infect Dis. 2020;90:188-196.

[[14]] Kocourkova A, Honegr J, Kuca K, et al.Vaccine ingredients: components that influence vaccine efficacy. Mini Rev Med Chem. 2017;17(5):451-466.

[[15]] Guimarães LE, Baker B, Perricone C, et al.Vaccines, adjuvants and autoimmunity. Pharmacol Res. 2015;100:190-209.

[[16]] Baden LR, El Sahly HM, Essink B, et al.Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl [J] Med. 2021;384(5):403-416.

[[17]] Corbett KS, Edwards DK, Leist SR, et al.SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586(7830):567-571.

[[18]] Polack FP, Thomas SJ, Kitchin N, et al.Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl [J] Med. 2020;383(27):2603-2615.

[[19]] Vogel AB, Kanevsky I, Che Y, et al.A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates. bioRxiv. 2020:280818.

[[20]] Jackson LA, Anderson EJ, Rouphael NG, et al.An mRNA vaccine against SARS-CoV-2 - preliminary report. N Engl [J] Med. 2020;383(20):1920-1931.

[[21]] Walsh EE, Frenck RW Jr, Falsey AR, et al.Safety and immunogenicity of two RNA-based covid-19 vaccine candidates. N Engl [J] Med. 2020;383(25):2439-2450.

[[22]] Rzymski P, Camargo CA Jr, Fal A, et al.COVID-19 vaccine boosters: the good, the bad, and the ugly. Vaccines (Basel). 2021;9(11):1299.

[[23]] Azike CG, Charpentier PA, Lui EM.Stimulation and suppression of innate immune function by American ginseng polysaccharides: biological relevance and identification of bioactives. Pharm Res. 2015;32(3):876-897.

[[24]] Meng LZ, Feng K, Wang LY, et al.Activation of mouse macrophages and dendritic cells induced by polysaccharides from a novel Cordyceps sinensis fungus UM01. [J] Funct Foods. 2014;9:242-253.

[[25]] Chavda VP, Patel AB, Vaghasiya DD.SARS-CoV-2 variants and vulnerability at the global level. [J] Med Virol. 2022;94(7):2986-3005.

[[26]] Coutinho RM, Marquitti FMD, Ferreira LS, et al.Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant. Commun Med (Lond). 2021;1:48.

[[27]] Gálvez JM, Chaparro-Solano HM, Pinzón-Rondón AM, et al.Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia. Infect Genet Evol. 2022;97:105192.

[[28]] Kannan S, Shaik Syed Ali P, Sheeza A. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review. Eur Rev Med Pharmacol Sci. 2021;25(24):8019-8022.

[[29]] Bernheim A, Sorek R. The pan-immune system of bacteria: antiviral defence as a community resource. Nat Rev Microbiol. 2020;18(2):113-119.

[[30]] Wubben R, Efstathiou C, Stevenson NJ.The interplay between the immune system and viruses. Vitam Horm. 2021;117:1-15.

[[31]] McComb S, Thiriot A, Akache B, et al. Introduction to the immune system. Methods Mol Biol. 2019;2024:1-24.

[[32]] Barman S, Soni D, Brook B, et al.Precision vaccine development: cues from natural immunity. Front Immunol. 2022;12:662218.

[[33]] Chowdhury MA, Hossain N, Kashem MA, et al.Immune response in COVID-19: A review. [J] Infect Public Health. 2020;13(11):1619-1629.

[[34]] Zeli Z, Jose M, Coelho CH, et al.Humoral and cellular immune memory to four COVID-19 vaccines. Cell. 2022;185(14):2434-2451.

[[35]] Behrens G, Li M, Smith CM, et al.Helper T cells, dendritic cells and CTL Immunity. Immunol Cell Biol. 2004;82(1):84-90.

[[36]] Tomar N, De RK.A brief outline of the immune system. Methods Mol Biol. 2014;1184:3-12.

[[37]] Kondo M, Weissman IL, Akashi K.Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997;91(5):661-672.

[[38]] Biron CA, Nguyen KB, Pien GC, et al.Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189-220.

[[39]] Iannello A, Raulet DH.Immune surveillance of unhealthy cells by natural killer cells. Cold Spring Harb Symp Quant Biol. 2013;78:249-257.

[[40]] Wagstaffe HR, Clutterbuck EA, Bockstal V, et al.Antibody-dependent natural killer cell activation after ebola vaccination. [J] Infect Dis. 2021;223(7):1171-1182.

[[41]] Langers I, Renoux V, Reschner A, et al.Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer. Eur [J] Immunol. 2014;44(12):3585-3595.

[[42]] Flórez-Álvarez L, Hernandez JC, Zapata W. NK cells in HIV-1 infection: from basic science to vaccine strategies. Front Immunol. 2018;9:2290.

[[43]] Hofmann M, Thimme R.Hepatitis B vaccine and NK cells: a new player in memory. Gut. 2021;70(2):229-230.

[[44]] Lanier LL.NK cell recognition. Annu Rev Immunol. 2005;23:225-274.

[[45]] Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 2004;23(2):255-259.

[[46]] Peng W, Qin R, Li X, et al.phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb.et Zucc.: a review. [J] Ethnopharmacol. 2013;148(3):729-745.

[[47]] Chueh FS, Lin JJ, Lin JH, et al.Crude extract of Polygonum cuspidatum stimulates immune responses in normal mice by increasing the percentage of Mac-3-positive cells and enhancing macrophage phagocytic activity and natural killer cell cytotoxicity. Mol Med Rep. 2015;11(1):127-132.

[[48]] Han R, Wu WQ, Wu XP, et al.Effect of total flavonoids from the seeds of Astragali complanati on natural killer cell function. [J] Ethnopharmacol. 2015;173:157-165.

[[49]] Lin SY, Liu LM, Wu LC.Effects of Shenmai Injection on Immune Function in Stomach Cancer Patients after Chemotherapy. Chin [J] Integr Med. 1995;15(8):451-453.

[[50]] Zhu XB, Guo M, Zhang ZH, et al. Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review. Integr Med Res. 2021;10(4):100778.

[[51]] Beutler B.Innate immunity: an overview. Mol Immunol. 2004;40(12):845-859.

[[52]] Kende M.Role of macrophages in the expression of immune responses. [J] Am Vet Med Assoc. 1982;181(10):1037-1042.

[[53]] Zhao Q, Wang Q, Wang T, et al. Pattern recognition receptors (PRRs) in macrophages possess prognosis and immunotherapy potential for melanoma. Front Immunol. 2021;12:765615.

[[54]] Law SK. C3 receptors on macrophages. [J] Cell Sci Suppl. 1988;9:67-97.

[[55]] Park EJ, Lee HS, Lee SJ, et al.Cigarette smoke condensate may disturb immune function with apoptotic cell death by impairing function of organelles in alveolar macrophages. Toxicol In Vitro. 2018;52:351-364.

[[56]] Taylor PR, Martinez-Pomares L, Stacey M, et al. Macrophage receptors and immune recognition. Annu Rev Immunol. 2005;23:901-944.

[[57]] Frémont L.Biological effects of resveratrol. Life Sci. 2000;66(8):663-673.

[[58]] Chen M, Chen X, Song X, et al. The immune-adjuvant activity and the mechanism of resveratrol on pseudorabies virus vaccine in a mouse model. Int Immunopharmacol. 2019;76:105876.

[[59]] Phull AR, Ahmed M, Park HJ. Cordyceps militaris as a bio functional food source: pharmacological potential, anti-inflammatory actions and related molecular mechanisms. Microorganisms. 2022;10(2):405.

[[60]] Lee JS, Hong EK.Immunostimulating activity of the polysaccharides isolated from Cordyceps militaris. Int Immunopharmacol. 2011;11(9):1226-1233.

[[61]] Shin MS, Park SB, Shin KS. Molecular mechanisms of immunomodulatory activity by polysaccharide isolated from the peels of Citrus unshiu. Int [J] Biol Macromol. 2018;112:576-583.

[[62]] Li WJ, Tang XF, Shuai XX, et al. Mannose receptor mediates the immune response to ganoderma atrum polysaccharides in macrophages. [J] Agric Food Chem. 2017;65(2):348-357.

[[63]] Lan H, Cheng Y, Mu J, et al. Glucose-rich polysaccharide from dried “Shixia” longan activates macrophages through Ca2+ and CR3- mediated MAPKs and PI3K-AKT pathways. Int [J] Biol Macromol. 2021;167:845-853.

[[64]] Zhou L, Liu Z, Wang Z, et al. Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo. Sci Rep. 2017;7:44822.

[[65]] Jia X, Zhang C, Hu J, et al. Ultrasound-assisted extraction, antioxidant and anticancer activities of the polysaccharides from rhynchosia minima root. Molecules. 2015;20(11):20901-20911.

[[66]] Jia X, Liang Y, Zhang C, et al. Polysaccharide PRM3 from Rhynchosia minima root enhances immune function through TLR4-NF-κB pathway. Biochim Biophys Acta Gen Subj. 2018;1862(8):1751-1759.

[[67]] Lee SG, Jung JY, Shin JS, et al. Immunostimulatory polysaccharide isolated from the leaves of Diospyros kaki Thumb modulate macrophage via TLR2. Int [J] Biol Macromol. 2015;79:971-982.

[[68]] Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245-252.

[[69]] Wan H, Dupasquier M. Dendritic cells in vivo and in vitro. Cell Mol Immunol. 2005;2(1):28-35.

[[70]] Labeur MS, Roters B, Pers B, et al.Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. [J] Immunol. 1999;162(1):168-175.

[[71]] Gardner A, Ruffell B. Dendritic cells and cancer immunity. Trends Immunol. 2016;37(12):855-865.

[[72]] Lu CN, Yuan ZG, Zhang XL, et al. Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-κB signaling pathway. Int Immunopharmacol. 2012;14(1):121-126.

[[73]] Wong VK, Zhang MM, Zhou H, et al. Saikosaponin-d enhances the anticancer potency of TNF-α via overcoming its undesirable response of activating NF-kappa B signalling in cancer cells. Evid Based Complement Alternat Med. 2013;2013:745295.

[[74]] Ying ZL, Li XJ, Dang H, et al. Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells. Exp Ther Med. 2014;7(5):1354-1358.

[[75]] Sun B, Yu S, Zhao D, et al. Polysaccharides as vaccine adjuvants. Vaccine. 2018;36(35):5226-5234.

[[76]] Sun P, Kim Y, Lee H, et al.Carrot Pomace Polysaccharide (CPP) improves influenza vaccine efficacy in immunosuppressed mice via dendritic cell activation. Nutrients. 2020;12(9):2740.

[[77]] Huang Y, Jiang C, Hu Y, et al. Immunoenhancement effect of rehmannia glutinosa polysaccharide on lymphocyte proliferation and dendritic cell. Carbohydr Polym. 2013;96(2):516-521.

[[78]] Wang Y, Kwak M, Lee PC, et al. Rehmannia glutinosa polysaccharide promoted activation of human dendritic cells. Int [J] Biol Macromol. 2018;116:232-238.

[[79]] Han JM, Song HY, Seo HS, et al. Immunoregulatory properties of a crude extraction fraction rich in polysaccharide from Chrysanthemum zawadskii Herbich var. latilobum and its potential role as a vaccine adjuvant. Int Immunopharmacol. 2021;95:107513.

[[80]] Zhu N, Lv X, Wang Y, et al. Comparison of immunoregulatory effects of polysaccharides from three natural herbs and cellular uptake in dendritic cells. Int [J] Biol Macromol. 2016;93(Pt A):940-951.

[[81]] Kim WS, Han JM, Song HY, et al. Annona muricata L.-derived polysaccharides as a potential adjuvant to a dendritic cell-based vaccine in a thymoma-bearing model. Nutrients. 2020;12(6):1602.

[[82]] Li X, He X, Liu B, et al. Maturation of murine bone marrow-derived dendritic cells induced by Radix Glycyrrhizae polysaccharide. Molecules. 2012;17(6):6557-6568.

[[83]] Huang D, Nie S, Jiang L, et al. A novel polysaccharide from the seeds of Plantago asiatica L. induces dendritic cells maturation through toll-like receptor 4. Int Immunopharmacol. 2014;18(2):236-243.

[[84]] Li J, Wang X, Wang W, et al. Pleurotus ferulae water extract enhances the maturation and function of murine bone marrow-derived dendritic cells through TLR4 signaling pathway. Vaccine. 2015;33(16):1923-1933.

[[85]] Li J, Li J, Zhang F.The immunoregulatory effects of Chinese herbal medicine on the maturation and function of dendritic cells. [J] Ethnopharmacol. 2015;171:184-195.

[[86]] Kumar BV, Connors TJ, Farber DL.Human T cell development, localization, and function throughout life. Immunity. 2018;48(2):202-213.

[[87]] Guerder S, Flavell RA.T-cell activation. Two for T. Curr Biol. 1995;5(8):866-868.

[[88]] Luckheeram RV, Zhou R, Verma AD, et al.CD4+T cells: differentiation and functions. Clin Dev Immunol. 2012;2012:1-12.

[[89]] Del Prete G.Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergyt. 1992;47(5):450-455.

[[90]] Raphael I, Nalawade S, Eagar TN, et al. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5-17.

[[91]] Mittrucker HW, Visekruna A, Huber M. Heterogeneity in the differentiation and function of CD8(+) T cells. Arch Immunol Ther Exp (Warsz). 2014;62(6):449-458.

[[92]] Kidd P.Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8(3):223-246.

[[93]] Bruno G, Saracino A, Monno L, et al.The revival of an “Old” marker: CD4/CD8 Ratio. AIDS Rev. 2017;19(2):81-88.

[[94]] Yang L, Hu Y, Xue J, et al.Compound Chinese herbal medicinal ingredients can enhance immune response and efficacy of RHD vaccine in rabbit. Vaccine. 2008;26(35):4451-4455.

[[95]] Caspi RR. Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int Rev Immunol. 2002;21(2-3):197-208.

[[96]] Tian QM, Bi HS, Cui Y, et al. Influence of Yanyankang Powder on Th1/Th2 in rats with experimental autoimmune uveitis. Chin [J] Integr Med. 2016;22(3):214-218.

[[97]] Zhao H, Li Y, Wang Y, et al.Antitumor and immunostimulatory activity of a polysaccharide-protein complex from Scolopendra subspinipes mutilans L. Koch in tumor-bearing mice. Food Chem Toxicol. 2012;50(8):2648-2655.

[[98]] Yang Y, Zhou Y. Shashen-maidong decoction-mediated IFN-γ and IL-4 on the regulation of Th1/Th2 imbalance in RP rats. Biomed Res Int. 2019;2019:6012473.

[[99]] Su CX, Duan XG, Liang LJ, et al. Lycium barbarum polysaccharides as an adjuvant for recombinant vaccine through enhancement of humoral immunity by activating Tfh cells. Vet Immunol Immunopathol. 2014;158(1-2):98-104.

[[100]] Bao Y, Jing C, Shi W. Effects of Chinese herbal recipes on immunity in immunosuppressive mice. Afr [J] Tradit Complement Altern Med. 2012;9(4):548-552.

[[101]] Chen X, Cao Z, Zhang Y, et al. Fuzheng qingjie granules inhibit growth of hepatoma cells via inducing mitochondria-mediated apoptosis and enhancing immune function. Integr Cancer Ther. 2017;16(3):329-338.

[[102]] Vos Q, Lees A, Wu ZQ, et al. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev. 2000;176(1):154-170.

[[103]] Linnik JE, Egli A.Impact of host genetic polymorphisms on vaccine induced antibody response. Hum Vaccin Immunother. 2016;12(4):907-915.

[[104]] Honda-Okubo Y, Saade F, Petrovsky N. Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses. Vaccine. 2012;30(36):5373-5381.

[[105]] Yang Z, Wang Y, Zheng Z, et al. Antiviral activity of Isatis indigotica root-derived clemastanin B against human and avian influenza A and B viruses in vitro. Int [J] Mol Med. 2013;31(4):867-873.

[[106]] Zhang W, Zheng X, Cheng N, et al. Isatis indigotica root polysaccharides as adjuvants for an inactivated rabies virus vaccine. Int [J] Biol Macromol. 2016;87:7-15.

[[107]] Han SB, Park SH, Lee KH, et al.Polysaccharide isolated from the radix of Platycodon grandiflorum selectively activates B cells and macrophages but not T cells. Int Immunopharmacol. 2001;1(11):1969-1978.

[[108]] Yang SF, Zhuang TF, Si YM, et al. Coriolus versicolor mushroom polysaccharides exert immunoregulatory effects on mouse B cells via membrane Ig and TLR-4 to activate the MAPK and NF-κB signaling pathways. Mol Immunol. 2015;64(1):144-151.

[[109]] Xie Y, Wang L, Sun H, et al. A polysaccharide extracted from alfalfa activates splenic B cells by TLR4 and acts primarily via the MAPK/p38 pathway. Food Funct. 2020;11(10):9035-9047.

[[110]] Han SB, Kim YH, Lee CW, et al. Characteristic immunostimulation by angelan isolated from Angelica gigas Nakai. Immunopharmacology. 1998;40(1):39-48.

[[111]] Han SB, Park SK, Ahn HJ, et al.Characterization of B cell membrane receptors of polysaccharide isolated from the root of Acanthopanax koreanum. Int Immunopharmacol. 2003;3(5):683-691.

[[112]] Han SB, Yoon YD, Ahn HJ, et al.Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus. Int Immunopharmacol. 2003;3(9):1301-1312.

[[113]] Jara A, Undurraga EA, González C, et al.Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. N Engl [J] Med. 2021;385(10):875-884.

[[114]] Chen Y, Yin S, Tong X, et al.Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine. Clin Microbiol Infect. 2022;28(3):410-418.

[[115]] Tarke A, Coelho CH, Zhang Z, et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell. 2022;185(5):847-859.e11.

[[116]] de Vries RD. SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity. Signal Transduct Target Ther. 2020;5(1):224.

[[117]] Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181(7):1489-1501.e15.

[[118]] Weiskopf D, Schmitz KS, Raadsen MP, et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol. 2020;5(48):eabd2071.

[[119]] Schulien I, Kemming J, Oberhardt V, et al.Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells. Nat Med. 2021;27(1):78-85.